Accueil
Détail de l'éditeur
Publications Office of the European Union
localisé à :
Luxembourg
|
Documents disponibles chez cet éditeur (177)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
The aim of this 'quick guide' is to make practical information on prevention quality standards available outside the European Union. A condensed version of EMCDDA Manual 7, it includes a description of the eight stages involved in the drug preve[...]Document multimédia
FRANÇAIS : La diversification de l'offre et de l'usage de drogues crée de nouvelles problématiques pour la politique en matière de drogue, de soins et de santé en Europe. [...] Ce rapport fournit la dernière vue d'ensemble existante de la situa[...]Rapport
ENGLISH: This handbook has been developed with the primary purpose of providing specific reference material for the European Prevention Curriculum (EUPC) training courses. It also serves to provide a more general introduction to prevention scie[...]Rapport
OEDT = EMCDDA ; T. NÉFAU ; E. LEFRANÇOIS ; V. DETREZ ; T. SEYLER ; B. GUARITA ; ESCAPE Network | Lisbon : OEDT / EMCDDA | Technical reports | 2021This protocol documents a new approach that has been developed to monitor substances injected by people who inject drugs through analytically confirmed data at the local level: the analysis of residual content of used syringes. Used syringes con[...]Rapport
This document summarises the main issues concerning evaluation in the field of drug policy. Aimed at those managing rather than undertaking drug policy evaluations, the guide acts as an introduction, providing links to the wider literature. Reco[...]Rapport
T. FRIIS SOGAARD ; M. HOJLUND BRAEMER ; M. MULBJERG PEDERSEN | Lisbon : OEDT / EMCDDA | Technical reports | 2021This report provides an analysis of current drug supply models and the related violence and exploitation of vulnerable groups in Denmark. Recent years have seen a growth in criminals' exploitation of vulnerable groups for drug-related crimes. Th[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; T. GROSHKOVA ; D. THANKI ; A. CUNNINGHAM ; M. RYCHERT | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014Concerns about the availability and use of methamphetamine in Europe have been growing for some time. Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of m[...]Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. CHRISTIE ; S. SOLA ; A. ALMEIDA ; R. JORGE ; J. DE MORAIS ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2018In this update from the EU Early Warning System, the EMCDDA aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency's early warning and risk-assessment activities. This report cov[...]Rapport
OEDT = EMCDDA ; C. COSTA STORTI ; D. FRASQUILHO ; G. BURKHART ; M. MOREIRA | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014The economic crisis that Europe experienced in 2008 and later presented a grave challenge to public finances. Countries responded to this by undertaking fiscal consolidation. By examining public expenditure in the areas where most drug-related a[...]Congrès
First European conference on drug supply indicators (20-22 October 2010; Brussels, Belgium) | Lisbon : OEDT / EMCDDA | Conference proceedings | 2010The conference was organised around three main thematic areas: the drug market, the drug-crime nexus, and drug supply reduction. In practical terms, the conference provided an opportunity to assess the current state of the art in data availabili[...]Rapport
Rapport
In November 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide, commonly known as furanylfentanyl, through a joint assessment. Furanylf[...]Rapport
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 23 May 2017. On the ba[...]Rapport
F. TRAUTMANN ; B. KILMER ; P. TURNBULL | Bruxelles : Commission européenne, Direction générale justice et affaires intérieures, Coordination de la lutte anti-drogue | 2013Highlights [Extracts]: * Our estimates for the EU cannabis market suggest a range of approximately €7 billion to €10 billion for 2010. These estimates are likely low as they do not account for the "consumption gap" that is created when data fro[...]Rapport
Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of ri[...]